Cardinal to buy private generic drug distributor for US$1.12 billion
Published Fri, Jun 5, 2015 · 11:26 AM
[BENGALURU] Cardinal Health Inc said it would buy privately held drug distributor Harvard Drug Group for US$1.12 billion.
Cardinal said it expects the deal to add more than 15 US cents per share to adjusted earnings from continuing operations in 2016 and 17 US cents per share in 2017.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action
France's Casino supermarket chain to axe up to 3,200 jobs
Prada outshines rivals with 16% revenue lift boosted by Miu Miu
Toymaker Hasbro posts quarterly profit beat, slower sales decline